The IMS Health Ruling: Some Thoughts on its Significance for Legal Practice and its Consequences for Future Cases such as Microsoft

Autor: J.C.A. Houdijk
Rok vydání: 2005
Předmět:
Zdroj: European Business Organization Law Review, 6, 3, pp. 467-495
European Business Organization Law Review, 6, 467-495
ISSN: 1741-6205
1566-7529
DOI: 10.1017/s1566752905004672
Popis: In its ruling in IMS Health, the European Court of Justice formulates four cumulative conditions to test whether there has been abuse of a dominant position within the meaning of Article 82 EC in the case of a refusal to license an intellectual property right (IPR). The Community courts only find an abuse of dominance in cases of non-licensing of an IPR in ‘exceptional circumstances’. The four conditions are an elaboration of this main criterion, and they revolve around the elements of ‘indispensability’, ‘new product’, ‘exclusion of all competition’ and ‘objective grounds for a licence refusal’.
Databáze: OpenAIRE